Clinical trial
Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients…
NCT00335738 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00335738 |
|---|---|
| Title | Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma |
| Official title | A Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Intraocular Retinoblastoma |
| Intervention type | Drug |
| Interventions | liposomal vincristine sulfate, carboplatin, etoposide |
| Enrollment | 331 |
| Start date | Dec 1, 2005 |
| Primary completion | Sep 1, 2011 |
| Completion | Sep 30, 2020 |
| First posted | Jun 12, 2006 |
| Last update posted | Feb 18, 2021 |
| Countries | Australia, Canada, India, New Zealand, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: